GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PureTech Health PLC (OTCPK:PTCHF) » Definitions » 14-Day RSI

PureTech Health (PureTech Health) 14-Day RSI : 51.12 (As of May. 01, 2024)


View and export this data going back to 2015. Start your Free Trial

What is PureTech Health 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2024-05-01), PureTech Health's 14-Day RSI is 51.12.

The industry rank for PureTech Health's 14-Day RSI or its related term are showing as below:

PTCHF's 14-Day RSI is ranked worse than
79.47% of 1573 companies
in the Biotechnology industry
Industry Median: 46.11 vs PTCHF: 51.12

Competitive Comparison of PureTech Health's 14-Day RSI

For the Biotechnology subindustry, PureTech Health's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PureTech Health's 14-Day RSI Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PureTech Health's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where PureTech Health's 14-Day RSI falls into.



PureTech Health  (OTCPK:PTCHF) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PureTech Health  (OTCPK:PTCHF) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


PureTech Health 14-Day RSI Related Terms

Thank you for viewing the detailed overview of PureTech Health's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


PureTech Health (PureTech Health) Business Description

Traded in Other Exchanges
Address
6 Tide Street, Suite 400, Boston, MA, USA, 02210
PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Internal, Controlled Founded Entities, Non-Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.

PureTech Health (PureTech Health) Headlines

From GuruFocus

PureTech Health: Notice of Results

By Business Wire Business Wire 04-13-2023

PureTech to Present at the Barclays Global Healthcare Conference

By Business Wire Business Wire 03-01-2023

PureTech Provides End of Year Report on Key Progress

By Business Wire Business Wire 12-22-2022

PureTech Year End Update and Outlook for 2024

By Business Wire 12-20-2023